Hrynkow Sharon Hemond
- SEC CIK
- 0001745677
No open-market purchases or sales filed in the past year.
Current role at each company
- FWDI Forward Industries, Inc.Directoras of Sep 11, 2025
- CYTH Cyclo Therapeutics, Inc.Chief Scientific Officeras of Dec 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hrynkow Sharon Hemond as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FWDI Forward Industries, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2022 (view filing) | Dec 20 | 1 day | Hrynkow Sharon HemondDirector | PPurchase | +9.86K | $1.14 | +$11.3K | +197.1%14.9K after | 2 lots |
CYTH Cyclo Therapeutics, Inc.
Chief Scientific Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 (view filing) | Dec 2 | Same day | Hrynkow Sharon HemondChief Scientific Officer | PPurchase | +1.00K | $4.98 | +$4.98K | +5.4%19.4K after |